Skip to content
Clinical Trials – home
GermanyBack to Germany

Clinical trials in Hemer

40 clinical trials in Hemer, Germany across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.

GermanyOur site in GermanyKlinischeStudien.de(opens in a new tab)
Hemer at a glance
40
clinical trials
  • Paediatric trials0
  • Research sites1
Type of trial
Recruitment status
Quick filters

40 trials in Hemer

Open in trial search
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Carboplatin
  • Sponsor:AstraZeneca AB
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Carboplatin
  • Sponsor:AstraZeneca AB
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Carboplatin
  • Sponsor:Pfizer Inc.
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Carboplatin
  • Sponsor:Merck Sharp & Dohme LLC
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Carboplatin
  • Sponsor:Bristol-Myers Squibb Services Unlimited Company
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Adagrasib
  • Sponsor:Bristol-Myers Squibb Services Unlimited Company
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Topotecan
  • Sponsor:Gilead Sciences Inc.
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Budigalimab
  • Sponsor:AbbVie Deutschland GmbH & Co. KG
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Carboplatin
  • Sponsor:Heidelberg University
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Durvalumab
  • Sponsor:University Of Cologne
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Adagrasib
  • Sponsor:Mirati Therapeutics Inc.

Other cities in Germany

The busiest research cities in the country

All 515 cities in Germany

Clinical research in Hemer

What the registry says about research in the country

01 Lung Cancer Research

Extensive clinical trials focusing on non-small cell lung cancer (NSCLC) treatments, including studies of novel drug combinations and immunotherapy approaches.

  • Advanced and Metastatic NSCLC
  • Stage II-IIIB Resectable NSCLC
  • KRAS G12C Mutations

Research emphasis on combination therapies involving immunotherapy agents and targeted treatments for specific genetic mutations.

02 Small Cell Lung Cancer Studies

Investigations into new treatment approaches for small cell lung cancer (SCLC), particularly focusing on maintenance therapy and immunotherapy combinations.

  • Limited Disease SCLC
  • Advanced/Metastatic SCLC
  • Durvalumab Combinations

Trials evaluating novel therapeutic strategies including chemotherapy with immunotherapy combinations.

03 Pulmonary Fibrosis Research

Clinical studies examining treatments for various forms of pulmonary fibrosis, including both idiopathic and progressive forms.

  • Idiopathic Pulmonary Fibrosis (IPF)
  • Progressive Fibrosing ILD
  • Long-term Treatment Effects

Focus on improving lung function and evaluating new therapeutic compounds for fibrotic lung diseases.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.